SCHEMBL9744815

SCHEMBL9744815

CCOC(=O)C(N)/C=C/CP(=O)(O)O

nearest known ligand 0.55

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.55
CYP2C9 P11712 1/20 0.55
CYP2C19 P33261 1/20 0.55
LAP3 P28838 1/20 0.35
GRIN2D O15399 1/20 0.34
GRIN3B O60391 1/20 0.34
GRIN1 Q05586 1/20 0.34
GRIN2A Q12879 1/20 0.34
GRIN2B Q13224 1/20 0.34
GRIN2C Q14957 1/20 0.34
GRIN3A Q8TCU5 1/20 0.34
ALOX15 P16050 2/20 0.33
ALDH1A1 P00352 4/20 0.32
TDP1 Q9NUW8 2/20 0.32
METAP1 P53582 2/20 0.32
CYP3A4 P08684 1/20 0.31
TSHR P16473 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9744820 1.00 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19LAP3GRIN2D
SCHEMBL9744681 0.87 CYP2D6 (0.42) CYP2D6CYP2C9CYP2C19LAP3GRIN2D
SCHEMBL9744696 0.87 CYP2D6 (0.42) CYP2D6CYP2C9CYP2C19LAP3GRIN2D
SCHEMBL9746246 0.84 CYP2D6 (0.40) CYP2D6CYP2C9CYP2C19LAP3ALDH1A1
SCHEMBL9746256 0.84 CYP2D6 (0.40) CYP2D6CYP2C9CYP2C19LAP3ALDH1A1
SCHEMBL9743658 0.83 CYP2D6 (0.39) CYP2D6CYP2C9CYP2C19LAP3GRIN2D
SCHEMBL9743040 0.83 LAP3 (0.40) CYP2D6CYP2C9CYP2C19LAP3
SCHEMBL9742659 0.82 LAP3 (0.41) LAP3ALDH1A1
SCHEMBL9745371 0.82 LAP3 (0.41) LAP3ALDH1A1
SCHEMBL9743708 0.81 CYP2D6 (0.37) CYP2D6CYP2C9CYP2C19LAP3GRIN2D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed